After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
OCUL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Ocular Therapeutix Inc is $2.11B. A total of 1.65 million shares were traded on the day, compared to an average of 2.36M shares.
In the most recent transaction, Waheed Nadia sold 13,861 shares of OCUL for 8.05 per share on Jun 02 ’25. After the transaction, the Chief Medical Officer now owns 206,805 company shares. In a previous transaction on Jun 02 ’25, NADIA K. WAHEED bought 13,861 shares at 8.05 per share.
Among the insiders who sold shares, Nayak Sanjay disposed of 1,862 shares on May 23 ’25 at a per-share price of $7.17. This resulted in the Chief Strategy Officer holding 281,623 shares of OCUL after the transaction. In another insider transaction, Kaiser Peter sold 2,974 shares at $7.17 per share on May 23 ’25. Company shares held by the Chief Development Officer now total 207,104.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, OCUL has a high of $12.91 and a low of $5.78.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. OCUL’s latest balance sheet shows that the firm has $164.16M in Cash & Short Term Investments as of fiscal 2021. There were $58.98M in debt and $26.34M in liabilities at the time. Its Book Value Per Share was $1.77, while its Total Shareholder’s Equity was $88.00M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OCUL is Buy with a score of 4.54.
